Best in Biotech 25 Feb 2025 Seven biotech spinouts to watch out for in 2025 …means to turn research into products of commercial value, the biotech industry has witnessed quite a few spinouts develop from research projects over the years. From treating neurodegenerative diseases and… February 25, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Mar 2018 This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases …neurodegenerative conditions from Alzheimer’s and Parkinson’s to traumatic brain injury. The anitbodies identify molecules involved in neurodegenerative diseases such as amyloid beta and α-synuclein, which could help diagnose diseases before… March 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Opinion 18 Dec 2023 What to expect from biotech clinical trials in the coming year …diseases will continue to attract clinical research in 2024, continuing a long-term trend, according to Calliditas’ Aguiar-Lucander, including genetic and pediatric diseases such as Duchenne muscular dystrophy, Alport syndrome and… December 18, 2023 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Nov 2024 Six exosome therapy companies driving development in the field …treating a number of diseases, such as cancer, neurological, and inflammatory diseases, several exosome therapy companies have come to the fore in recent times, with many just beginning to advance… November 12, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 8 Feb 2021 How Next-Generation Gene Therapy Tackles Complex Diseases Gene therapy has traditionally been applied to well-understood diseases where a single genetic mutation was to blame. A new generation of technology is expanding the potential of gene therapy to… February 8, 2021 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 12 Mar 2018 A Dutch Company on the Quest Against Cystic Fibrosis …multiple rare diseases caused by genetic mutations, such as hemophilia, porphyria, or iron overload disorders. “I thought, ‘if you can do that for all these other genetic diseases, why not… March 12, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2022 Proxidrugs: a new tool to fight pathogens? …pharmaceutical companies Merck and Abbvie. Three focuses The project is focusing on three indications: cancer, neurodegenerative diseases and infectious diseases. In all three fields, the aim is to eliminate the… September 1, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 24 Mar 2017 This Swedish Biotech Uses Bacteria to Treat Diseases in Infants This week’s biotech brought us to Scandinavia. Based in Sweden’s capital, Stockholm, Infant Bacterial Therapeutics aims to treat rare diseases affecting newborns by targeting the infant microbiome. Mission: Infant Bacterial… March 24, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 21 Aug 2024 The promise of antisense oligonucleotides in precision medicine …as cell proliferation, cell differentiation, immune response, and tissue modeling. Because it is chronically elevated in many diseases, including ophthalmic diseases, and is involved in their pathophysiology, it is an… August 21, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 18 Sep 2017 German Humira Biosimilar for Inflammatory Diseases Cleared for EMA Approval …for approval, moving it closer to the market and offering a new treatment for a range of inflammatory diseases. The biosimilar drug of adalimumab (Humira) could treat a wide range… September 18, 2017 - 1 minutemin - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 3 Mar 2023 Porton and DanausGT look to boost development of gene and cell therapy …nerve-related diseases, cancer, and skin diseases. The company has six major pipelines that cover blood diseases, skin diseases, and liver-related diseases. Several of these pipelines have obtained orphan drug designation… March 3, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 May 2023 Gilead boosts oncology pipeline with XinThera acquisition …body’s immune response in inflammatory diseases, both of which may improve outcomes for people living with these diseases,” said Flavius Martin, executive vice president, research, at Gilead Sciences. “Guided by… May 9, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email